Alto Neuroscience, Inc. (ANRO)
NYSE·Healthcare·Biotechnology
$26.77
-13.03%
Mkt Cap $1.06B
Analyst Ratings
Buy
10
Hold
3
Sell
0
Price Target (8 analysts)
$34.60
Range $24.00 – $50.00
Implied Upside
+29.2%
Consensus $34.60 vs current $26.77
NYSE·Healthcare·Biotechnology
$26.77
-13.03%
Mkt Cap $1.06B
Buy
10
Hold
3
Sell
0
Price Target (8 analysts)
$34.60
Range $24.00 – $50.00
+29.2%
Consensus $34.60 vs current $26.77